UAE
Testvox FZCO
Fifth Floor 9WC Dubai Airport Freezone
The medical device industry is changing fast. In the past to get a device approved by the Food and Drug Administration you had to show two things: the device was safe and it did what it was supposed to do. So if a scalpel was sharp and clean or if an imaging machine took pictures without hurting the patient that was good enough.
Now things are different. The idea of safety has changed. Since most modern medical devices can connect to the internet or have software a device is not safe if it can be easily attacked by hackers. The Food and Drug Administration is paying a lot of attention to making sure medical devices are protected from hackers, ransomware and system failures. For people who are creating medical devices understanding what the Food and Drug Administration requires is a crucial part of designing the product from the very beginning. Medical devices are a part of this and the Food and Drug Administration requirements are really important for medical devices to be safe.
The Food and Drug Administration divides the way it checks products into two parts: before the medical device is sold and after the medical device is being used by doctors and patients. To do well you need to show that you have a plan for the Food and Drug Administration to approve your medical device at both of these times the time before the medical device is sold and the time after the medical device is sold.
During the premarket review, the FDA looks for proof that you built security into the core architecture of your device, rather than trying to slap it on at the end of development. You are required to submit extensive technical documentation. This includes a clear Software Bill of Materials (SBOM), a detailed threat model identifying every potential point of entry for an attacker, and evidence of rigorous penetration testing. The agency wants to see the exact engineering choices you made to protect patient data and system integrity before a single unit is shipped.
Once your device receives clearance or approval, the regulatory clock does not stop. The FDA recognizes that cybersecurity is a living, breathing ecosystem. A device that is perfectly secure today could be vulnerable tomorrow if a new software exploit is discovered in the wild.
Postmarket requirements demand that manufacturers have an active monitoring program. You must track emerging threats, maintain a clear process for users to report bugs, and have the infrastructure in place to design, test, and deploy software updates and security patches swiftly.
If you speak with anyone in medical device regulatory affairs today, you will constantly hear mention of Section 524B of the Food, Drug, and Cosmetic (FD&C) Act. This specific amendment, which became legally enforceable in 2023 and has reached full regulatory maturity by 2026, completely changed the rules of engagement.
Before Section 524B, the FDA issued cybersecurity recommendations as “guidance documents.” While highly influential, they lacked strict statutory backing. Section 524B turned those recommendations into absolute legal mandates for any product classified as a “Cyber Device.”
According to the law, a cyber device is any piece of medical technology that contains software validated by or on behalf of the sponsor, has the ability to connect to the internet or an external network, and is vulnerable to cybersecurity threats. If your device meets these criteria, Section 524B legally binds you to three specific actions:
Failing to meet these conditions gives the FDA the direct statutory power to issue a Refuse to Accept (RTA) decision, halting your submission before a reviewer even reads your clinical data.
The FDA uses a risk based approach to regulation, which means the intensity of the cybersecurity review depends heavily on the device’s intent, architecture, and potential for patient harm.
Devices like pacemakers, implantable cardioverter defibrillators, and automated insulin pumps face the most intense level of scrutiny. Because these devices interact directly with human physiology, a security breach could have immediate, fatal consequences. For these products, the FDA expects zero trust architectures, deeply encrypted communication channels, and rigorous verification that a network exploit cannot drain the battery or alter medication delivery.
SaMD refers to standalone software applications that perform medical functions without being tied to specific hardware, such as an AI algorithm that analyzes radiological scans on a smartphone. For SaMD, the FDA focuses heavily on data integrity, secure cloud environments, and user authentication. Because these applications are updated frequently, the agency pays close attention to how you manage version control and protect the pipeline during remote updates.
Large scale hospital equipment, such as surgical robots or patient monitoring networks, presents a unique challenge. These devices act as gateways to broader hospital networks. The FDA expects manufacturers to design these systems to operate safely even if the surrounding hospital network is compromised by ransomware. They look for features like degraded mode operations, allowing the device to perform its core medical duties while completely disconnected from the local network.
Navigating the sea of regulatory paperwork can be overwhelming. The primary source for all official requirements is the FDA’s online Guidance Document Database. The single most important text for modern device developers is the final guidance titled “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.”
When reading an FDA guidance document, it is crucial to understand the regulatory language used. The agency is very deliberate with its word choices.
When a document says a manufacturer “should” do something, it technically means it is a recommendation, not a strict law. However, in the context of cybersecurity, treating a “should” as optional is a recipe for a delayed submission. Reviewers treat these recommendations as the baseline standard of excellence. If you choose not to follow a recommendation outlined in the guidance, you must provide an incredibly strong, legally defensible technical justification for why your alternative approach is just as secure.
Additionally, keep an eye on the FDA’s “Recognized Consensus Standards.” The agency frequently adopts standards established by international organizations, such as IEEE, ISO, and AAMI. Aligning your engineering processes with these recognized standards gives your submission a clear, structured path to approval.
While the road to meeting FDA cybersecurity requirements is long and demanding, it provides an undeniable commercial advantage.Hospital procurement boards are really careful about what they buy. They do not just look at the price. If the technology works well for patients. They want to see that the technology is secure and they want to know what is in it before they buy it.
They want to see that other people have checked the security and they want a list of all the parts that are used to make the technology.
If you make sure your technology is secure from the start you can avoid having to recall products, which can be very bad, for your company. You can also keep your place in the market. People will trust your company.
Hospital procurement boards and healthcare systems will see that you care about patients and you want to keep them safe. Security is not something that is nice to have, it is a very important part of taking care of patients. Hospital procurement boards and healthcare systems will trust your company if you show them that you care about security and patient care.
Let us know what you’re looking for, and we’ll connect you with a Testvox expert who can offer more information about our solutions and answer any questions you might have?